23-Valent Pneumococcal Polysaccharide Vaccine Market
23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Share & Trends Analysis Report
23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Share, Statistics & Trends Analysis Report By Type (Pre-filled Syringe, Single Dose Vial), By Age Group (2-10 Years, 10-64 Years, 64+ Years), By Distribution (Hospitals, Clinics, Others), Based On Region, And Segment Forecasts, 2022 – 2029
Published
Report ID : BMRC 2285
Number of pages : 300
Published Date : Jan 2023
Category : Vaccines
Delivery Timeline : 48 hrs
Key Players:
- Merck & Co., Inc.
- GlaxoSmithKline plc
- Walvax Biotechnology Co
- Chongqing Zhifei Biological Products Co Ltd
- Sinovac Biotech Ltd.
- Chengdu Institute of Biological Products Co., Ltd.
- Others
Segmentations:
By Type
- Pre-filled Syringe
- Single Dose Vial
By Age Group
- 2-10 Years
- 10-64 Years
- 64+ Years
By Distribution
- Hospitals
- Clinics
- Others
SUMMARY
Regions and Country
North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Sweden
- Netherlands
- Turkey
- Switzerland
- Belgium
- Rest of Europe
Asia-Pacific
- South Korea
- Japan
- China
- India
- Australia
- Philippines
- Singapore
- Malaysia
- Thailand
- Indonesia
- Rest of APAC
Latin America
- Mexico
- Colombia
- Brazil
- Argentina
- Peru
- Rest of South America
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of MEA
